mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.51 |
3e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0003 |